Alterity Therapeutics To Host Webcast To Discuss ATH434 Efficacy Data In Primates And Recent Clinical Progress

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, will be hosting an investor

Alterity Therapeutics ((ASX: ATH, NASDAQ:

Registration is required and dial in details will be sent directly upon registration.

Investors will have the opportunity to ask questions during the call, at the conclusion of the presentation. Investors are also able to submit questions in advance to Hannah Howlett at we-aualteritytherapeutics@we-worldwide.com

Total
0
Shares
Related Posts